IMPROVEMENTS IN AND RELATING TO MEDICINAL COMPOSITIONS

A composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naloxone such that the ratio by weight 5 of buprenorphine to naloxone delivered to or reaching the plasma of a patient is in the range of fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HYDE, NEIL, CHAPLEO, CHRISTOPHER BOURNE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HYDE, NEIL
CHAPLEO, CHRISTOPHER BOURNE
description A composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naloxone such that the ratio by weight 5 of buprenorphine to naloxone delivered to or reaching the plasma of a patient is in the range of from 7.5:1 to 12.4:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, which also serves to reduce the likelihood of abuse of the composition by drug addicts. Also provided are a method of treatment of pain and the use of naloxone and buprenorphine for the manufacture of a medicament. 70- -0-10.1 60- -m- BliP only 2- 40
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2014201777A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2014201777A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2014201777A13</originalsourceid><addsrcrecordid>eNrjZDDz9A0I8g9z9XX1CwlW8PRTcPRzUQhy9XEM8fRzVwjxV_B1dfF09vRz9FFw9vcN8A_2DPH09wvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoYmQGxubu5oaEycKgDDLyjk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMPROVEMENTS IN AND RELATING TO MEDICINAL COMPOSITIONS</title><source>esp@cenet</source><creator>HYDE, NEIL ; CHAPLEO, CHRISTOPHER BOURNE</creator><creatorcontrib>HYDE, NEIL ; CHAPLEO, CHRISTOPHER BOURNE</creatorcontrib><description>A composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naloxone such that the ratio by weight 5 of buprenorphine to naloxone delivered to or reaching the plasma of a patient is in the range of from 7.5:1 to 12.4:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, which also serves to reduce the likelihood of abuse of the composition by drug addicts. Also provided are a method of treatment of pain and the use of naloxone and buprenorphine for the manufacture of a medicament. 70- -0-10.1 60- -m- BliP only 2- 40</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140417&amp;DB=EPODOC&amp;CC=AU&amp;NR=2014201777A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140417&amp;DB=EPODOC&amp;CC=AU&amp;NR=2014201777A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HYDE, NEIL</creatorcontrib><creatorcontrib>CHAPLEO, CHRISTOPHER BOURNE</creatorcontrib><title>IMPROVEMENTS IN AND RELATING TO MEDICINAL COMPOSITIONS</title><description>A composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naloxone such that the ratio by weight 5 of buprenorphine to naloxone delivered to or reaching the plasma of a patient is in the range of from 7.5:1 to 12.4:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, which also serves to reduce the likelihood of abuse of the composition by drug addicts. Also provided are a method of treatment of pain and the use of naloxone and buprenorphine for the manufacture of a medicament. 70- -0-10.1 60- -m- BliP only 2- 40</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDz9A0I8g9z9XX1CwlW8PRTcPRzUQhy9XEM8fRzVwjxV_B1dfF09vRz9FFw9vcN8A_2DPH09wvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoYmQGxubu5oaEycKgDDLyjk</recordid><startdate>20140417</startdate><enddate>20140417</enddate><creator>HYDE, NEIL</creator><creator>CHAPLEO, CHRISTOPHER BOURNE</creator><scope>EVB</scope></search><sort><creationdate>20140417</creationdate><title>IMPROVEMENTS IN AND RELATING TO MEDICINAL COMPOSITIONS</title><author>HYDE, NEIL ; CHAPLEO, CHRISTOPHER BOURNE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2014201777A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HYDE, NEIL</creatorcontrib><creatorcontrib>CHAPLEO, CHRISTOPHER BOURNE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HYDE, NEIL</au><au>CHAPLEO, CHRISTOPHER BOURNE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMPROVEMENTS IN AND RELATING TO MEDICINAL COMPOSITIONS</title><date>2014-04-17</date><risdate>2014</risdate><abstract>A composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naloxone such that the ratio by weight 5 of buprenorphine to naloxone delivered to or reaching the plasma of a patient is in the range of from 7.5:1 to 12.4:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, which also serves to reduce the likelihood of abuse of the composition by drug addicts. Also provided are a method of treatment of pain and the use of naloxone and buprenorphine for the manufacture of a medicament. 70- -0-10.1 60- -m- BliP only 2- 40</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2014201777A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title IMPROVEMENTS IN AND RELATING TO MEDICINAL COMPOSITIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A26%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HYDE,%20NEIL&rft.date=2014-04-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2014201777A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true